Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today.
Revenues decreased 54% year-over-year to $12.7 billion.
Reported net income declined 77% to $2.3 billion, or $0.41 per share, compared to last year. Adjusted EPS fell 67% to $0.67.
While earnings beat expectations, revenue fell short of estimates.
For the full year of 2023, revenues are expected to range between $67-70 billion while adjusted EPS is estimated to range between $3.25-3.45.
The stock dropped 1% in premarket hours on Tuesday following the report.
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications